Coding variants in <i>PNPLA3</i> and <i>TM6SF2</i> are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.

Guzman, Cristina B; Duvvuru, Suman; Akkari, Anthony; Bhatnagar, Pallav; Battioui, Chakib; Foster, Wendra; Zhang, Xiaotian Michelle; Shankar, Sudha S; Deeg, Mark A; Chalasani, Naga; Hardy, Thomas A; Kazda, Christof M; Pillai, Sreekumar G

Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.

Guzman, Cristina B; Duvvuru, Suman; Akkari, Anthony; Bhatnagar, Pallav; Battioui, Chakib; Foster, Wendra; Zhang, Xiaotian Michelle; Shankar, Sudha S; Deeg, Mark A; Chalasani, Naga; Hardy, Thomas A; Kazda, Christof M; Pillai, Sreekumar G.

Guzman CB; Eli Lilly and Company Indianapolis IN.
Duvvuru S; Present address: Enanta Pharmaceuticals Inc Watertown MA.
Akkari A; Eli Lilly and Company Indianapolis IN.
Bhatnagar P; Present address: Amazon Seattle WA.
Battioui C; Cabernet Pharmaceuticals Durham NC.
Foster W; Eli Lilly and Company Indianapolis IN.
Zhang XM; Eli Lilly and Company Indianapolis IN.
Shankar SS; Eli Lilly and Company Indianapolis IN.
Deeg MA; Eli Lilly and Company Toronto Canada.
Chalasani N; Eli Lilly and Company Indianapolis IN.
Hardy TA; Present address: NGM Biopharmaceuticals San Francisco CA.
Kazda CM; Eli Lilly and Company Indianapolis IN.
Pillai SG; Present address: Regulus Pharmaceuticals San Diego CA.

Hepatol Commun ; 2(5): 561-570, 2018 May.

Article en En | MEDLINE | ID: mdl-29761171

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies Idioma: En Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies Idioma: En Año: 2018 Tipo del documento: Article